<DOC>
	<DOC>NCT00880711</DOC>
	<brief_summary>The purpose is to collect real life data on the use of fulvestrant in normal clinical practice in Austria and document the clinical benefit of fulvestrant treatment.</brief_summary>
	<brief_title>Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC)</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fulvestrant</mesh_term>
	<criteria>Postmenopausal women with hormone receptorpositive locally advanced or metastatic breast cancer Ability to read and write and complete questionnaires Provision of written informed consent Patients who already received a prescription for fulvestrant A subject who does not fulfil all the above mentioned inclusion criteria is not allowed to participate in this NIS</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Fiona</keyword>
	<keyword>Faslodex</keyword>
	<keyword>Advanced Breast Cancer</keyword>
	<keyword>Real life data</keyword>
	<keyword>Collect real life data in clinical practice across Austria</keyword>
</DOC>